MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice

Supplemental Digital Content is available in the text. Objective: Atherosclerosis is a leading cause of death in developed countries. MicroRNAs act as fine-tuners of gene expression and have been shown to have important roles in the pathophysiology and progression of atherosclerosis. We, and others, previously demonstrated that microRNA-144 (miR-144) functions to post-transcriptionally regulate ABCA1 (ATP binding cassette transporter A1) and plasma HDL (high-density lipoprotein) cholesterol levels. Here, we explore how miR-144 inhibition may protect against atherosclerosis. Approach and Results: We demonstrate that miR-144 silencing reduced atherosclerosis in male, but not female low-density lipoprotein receptor null (Ldlr−/−) mice. MiR-144 antagonism increased circulating HDL cholesterol levels, remodeled the HDL particle, and enhanced reverse cholesterol transport. Notably, the effects on HDL and reverse cholesterol transport were more pronounced in male mice suggesting sex-specific differences may contribute to the effects of silencing miR-144 on atherosclerosis. As a molecular mechanism, we identify the oxysterol metabolizing enzyme CYP7B1 (cytochrome P450 enzyme 7B1) as a miR-144 regulated gene in male, but not female mice. Consistent with miR-144-dependent changes in CYP7B1 activity, we show decreased levels of 27-hydroxycholesterol, a known proatherogenic sterol and the endogenous substrate for CYP7B1 in male, but not female mice. Conclusions: Our data demonstrate silencing miR-144 has sex-specific effects and that treatment with antisense oligonucleotides to target miR-144 might result in enhancements in reverse cholesterol transport and oxysterol metabolism in patients with cardiovascular disease.

[1]  J. Pelisek,et al.  Biobanking: Objectives, Requirements, and Future Challenges—Experiences from the Munich Vascular Biobank , 2019, Journal of clinical medicine.

[2]  Deanna L. Plubell,et al.  Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity[S] , 2019, Journal of Lipid Research.

[3]  K. Moore,et al.  The long noncoding RNA CHROME regulates cholesterol homeostasis in primate , 2018, Nature Metabolism.

[4]  M. Jagodic,et al.  Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  V. Chair,et al.  Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association. , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Amy S. Shah,et al.  Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1[S] , 2017, Journal of Lipid Research.

[7]  K. Moore,et al.  miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[8]  R. Charnigo,et al.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice[S] , 2016, Journal of Lipid Research.

[9]  A. Gabrielsen,et al.  Gene expression signatures, pathways and networks in carotid atherosclerosis , 2016, Journal of internal medicine.

[10]  Y. Tomari,et al.  The Functions of MicroRNAs: mRNA Decay and Translational Repression. , 2015, Trends in cell biology.

[11]  W. Filipowicz,et al.  The long unfinished march towards understanding microRNA-mediated repression , 2015, RNA.

[12]  C. Mineo,et al.  The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. , 2014, Cell metabolism.

[13]  Q. Wang,et al.  An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production , 2014, PloS one.

[14]  J. Segrest,et al.  Helical domains that mediate lipid solubilization and ABCA1-specific cholesterol efflux in apolipoproteins C-I and A-II[S] , 2013, Journal of Lipid Research.

[15]  J. Zavadil,et al.  Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144 , 2013, Circulation research.

[16]  P. Edwards,et al.  Abstract 76: MicroRNA-144 Regulates Hepatic ABCA1 and Plasma HDL Following Activation of the Nuclear Receptor FXR , 2013 .

[17]  Y. E. Chen,et al.  Human Apolipoprotein A-II Protects Against Diet-Induced Atherosclerosis in Transgenic Rabbits , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[18]  P. Edwards,et al.  Dancing with the sterols: critical roles for ABCG1, ABCA1, miRNAs, and nuclear and cell surface receptors in controlling cellular sterol homeostasis. , 2012, Biochimica et biophysica acta.

[19]  A. Dávalos,et al.  MicroRNA-758 Regulates Cholesterol Efflux Through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1 , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[20]  Aaron N. Chang,et al.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. , 2011, The Journal of clinical investigation.

[21]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[22]  S. Reddy,et al.  Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes , 2010, Diabetes.

[23]  Daniel S. Ory,et al.  miR-33 links SREBP-2 induction to repression of sterol transporters , 2010, Proceedings of the National Academy of Sciences.

[24]  K. Moore,et al.  MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.

[25]  P. Edwards,et al.  Impaired Development of Atherosclerosis in Abcg1−/− Apoe−/− Mice: Identification of Specific Oxysterols That Both Accumulate in Abcg1−/− Apoe−/− Tissues and Induce Apoptosis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[26]  D. Russell,et al.  CYP7B1: One Cytochrome P450, Two Human Genetic Diseases, and Multiple Physiological Functions* , 2009, The Journal of Biological Chemistry.

[27]  D. Bartel MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[28]  P. Rothwell,et al.  Critical Cap Thickness and Rupture in Symptomatic Carotid Plaques: The Oxford Plaque Study , 2008, Stroke.

[29]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[30]  K. Korach,et al.  27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen , 2007, Nature Medicine.

[31]  Andrew C. Li,et al.  Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr−/− and ApoE−/− Mice Transplanted With Abcg1−/− Bone Marrow , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Arnold,et al.  Tissue-specific expression and regulation of sexually dimorphic genes in mice. , 2006, Genome research.

[33]  F. D. de Beer,et al.  Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I* , 2005, Journal of Biological Chemistry.

[34]  M. Reilly,et al.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. , 2005, The Journal of clinical investigation.

[35]  E. Rubin,et al.  HDLs in apoA-I transgenic Abca1 knockout mice are remodeled normally in plasma but are hypercatabolized by the kidney Published, JLR Papers in Press, July 16, 2005. DOI 10.1194/jlr.M500179-JLR200 , 2005, Journal of Lipid Research.

[36]  Paul T. Tarr,et al.  ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. , 2005, Cell metabolism.

[37]  R. Peto,et al.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial , 2004, The Lancet.

[38]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[39]  P. Rothwell,et al.  Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[40]  G. Hutvagner,et al.  A microRNA in a Multiple-Turnover RNAi Enzyme Complex , 2002, Science.

[41]  A. Evans,et al.  Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease: The PRIME Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[42]  R. Lawn,et al.  ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.

[43]  P. Edwards,et al.  Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Russell,et al.  Disruption of the Oxysterol 7α-Hydroxylase Gene in Mice* , 2000, The Journal of Biological Chemistry.

[45]  A. Whitehead,et al.  Serum amyloid A, the major vertebrate acute-phase reactant. , 1999, European journal of biochemistry.

[46]  D. Russell,et al.  Two 7α‐hydroxylase enzymes in bile acid biosynthesis , 1998 .

[47]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[48]  W. J. Johnson,et al.  Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. , 1991, Journal of lipid research.

[49]  R. Krauss,et al.  Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.

[50]  G. Santulli,et al.  Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. , 2015, Advances in experimental medicine and biology.

[51]  N. Sonenberg,et al.  Understanding how miRNAs post-transcriptionally regulate gene expression. , 2010, Progress in molecular and subcellular biology.

[52]  D. Russell,et al.  Disruption of the oxysterol 7alpha-hydroxylase gene in mice. , 2000, The Journal of biological chemistry.

[53]  D. Russell,et al.  Two 7 alpha-hydroxylase enzymes in bile acid biosynthesis. , 1998, Current opinion in lipidology.